What This Document Is
These are lecture notes prepared for Pharmacology Exam One in NUR 3191 at Nova Southeastern University. The notes cover foundational concepts in pharmacology, including the definition of pharmacology itself, the roles of drugs (prevention, cure, diagnosis, relief), drug sources, classifications, and the historical regulatory framework governing drug development and safety in the United States. A significant portion details the phases of the U.S. FDA drug approval process and the scheduling of controlled substances.
Why This Document Matters
These notes are essential for nursing students preparing for their first pharmacology exam. Understanding these core principles is crucial for safe and effective medication administration, patient education, and clinical decision-making. The historical context of drug regulation provides insight into current practices and the importance of adhering to established protocols. This document serves as a concentrated review of key topics likely to be assessed on the exam.
Common Limitations or Challenges
This document is a condensed set of lecture notes and does *not* provide in-depth explanations of specific drug mechanisms or detailed treatment protocols. It’s a study *aid*, not a comprehensive pharmacology textbook. Students will still need to refer to their course textbook, assigned readings, and other resources for a complete understanding of the material. This preview does not include all details regarding controlled substance schedules.
What This Document Provides
The full document includes:
* A definition of pharmacology and the nurse’s role within the field.
* Examples of drugs used for prevention, cure, diagnosis, and relief.
* Classifications of drugs based on action, affected body system, and chemical characteristics.
* An explanation of prototype drugs and the difference between generic and trade names.
* A timeline of key U.S. legislation impacting drug regulation (Federal Food, Drug & Cosmetic Act, Harrison Narcotic Act, Durham-Humphrey Amendment, etc.).
* A breakdown of the FDA drug approval process (Phases 1-4).
* An overview of controlled substance schedules (I-IV).
This preview provides a high-level overview of these topics but does *not* include detailed information on specific drugs, dosages, or adverse effects.
